<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/> 
  <meta name="type" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/04/10/2020.04.09.034454.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.04.09.034454v1"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium"/>
  <meta name="DC.Identifier" content="10.1101/2020.04.09.034454"/>
  <meta name="DC.Date" content="2020-04-10"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="Â© 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="Coronavirus disease 2019 (COVID-19) outcomes vary from asymptomatic infection to death. This disparity may reflect different airway levels of the SARS-CoV-2 receptor, ACE2, and the spike protein activator, TMPRSS2. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci (eQTL) for both ACE2 and TMPRSS2, that vary in frequency across world populations. Importantly, we find TMPRSS2 is part of a mucus secretory network, highly upregulated by T2 inflammation through the action of interleukin-13, and that interferon response to respiratory viruses highly upregulates ACE2 expression. Finally, we define airway responses to coronavirus infections in children, finding that these infections upregulate IL6 while also stimulating a more pronounced cytotoxic immune response relative to other respiratory viruses. Our results reveal mechanisms likely influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="DC.Contributor" content="Satria P Sajuthi"/>
  <meta name="DC.Contributor" content="Peter DeFord"/>
  <meta name="DC.Contributor" content="Nathan D Jackson"/>
  <meta name="DC.Contributor" content="Michael T Montgomery"/>
  <meta name="DC.Contributor" content="Jamie L Everman"/>
  <meta name="DC.Contributor" content="Cydney L Rios"/>
  <meta name="DC.Contributor" content="Elmar Pruesse"/>
  <meta name="DC.Contributor" content="James D Nolin"/>
  <meta name="DC.Contributor" content="Elizabeth G Plender"/>
  <meta name="DC.Contributor" content="Michael E Wechsler"/>
  <meta name="DC.Contributor" content="Angel CY Mak"/>
  <meta name="DC.Contributor" content="Celeste Eng"/>
  <meta name="DC.Contributor" content="Sandra Salazar"/>
  <meta name="DC.Contributor" content="Vivian Medina"/>
  <meta name="DC.Contributor" content="Eric M Wohlford"/>
  <meta name="DC.Contributor" content="Scott Huntsman"/>
  <meta name="DC.Contributor" content="Deborah A Nickerson"/>
  <meta name="DC.Contributor" content="Soren Germer"/>
  <meta name="DC.Contributor" content="Michael C Zody"/>
  <meta name="DC.Contributor" content="Goncalo Abecasis"/>
  <meta name="DC.Contributor" content="Hyun Min Kang"/>
  <meta name="DC.Contributor" content="Kenneth M Rice"/>
  <meta name="DC.Contributor" content="Rajesh Kumar"/>
  <meta name="DC.Contributor" content="Sam Oh"/>
  <meta name="DC.Contributor" content="Jose Rodriguez-Santana"/>
  <meta name="DC.Contributor" content="Esteban G Burchard"/>
  <meta name="DC.Contributor" content="Max A Seibold"/>
  <meta name="article:published_time" content="2020-04-10"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;Coronavirus disease 2019 (COVID-19) outcomes vary from asymptomatic infection to death. This disparity may reflect different airway levels of the SARS-CoV-2 receptor, ACE2, and the spike protein activator, TMPRSS2. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci (eQTL) for both ACE2 and TMPRSS2, that vary in frequency across world populations. Importantly, we find TMPRSS2 is part of a mucus secretory network, highly upregulated by T2 inflammation through the action of interleukin-13, and that interferon response to respiratory viruses highly upregulates ACE2 expression. Finally, we define airway responses to coronavirus infections in children, finding that these infections upregulate IL6 while also stimulating a more pronounced cytotoxic immune response relative to other respiratory viruses. Our results reveal mechanisms likely influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.04.09.034454v1"/>
  <meta name="citation_id" content="2020.04.09.034454v1"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.04.09.034454v1"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.09.034454v1.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.09.034454v1.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/04/10/2020.04.09.034454.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.04.09.034454"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.04.09.034454"/>
  <meta name="citation_author" content="Satria P Sajuthi"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="sajuthis@njhealth.org"/>
  <meta name="citation_author" content="Peter DeFord"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="defordp@njhealth.org"/>
  <meta name="citation_author" content="Nathan D Jackson"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="jacksonna@njhealth.org"/>
  <meta name="citation_author" content="Michael T Montgomery"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="montgomerym@njhealth.org"/>
  <meta name="citation_author" content="Jamie L Everman"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="evermanj@njhealth.org"/>
  <meta name="citation_author" content="Cydney L Rios"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="urbanekc@njhealth.org"/>
  <meta name="citation_author" content="Elmar Pruesse"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="pruessee@njhealth.org"/>
  <meta name="citation_author" content="James D Nolin"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="nolinj@njhealth.org"/>
  <meta name="citation_author" content="Elizabeth G Plender"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="plendere@njhealth.org"/>
  <meta name="citation_author" content="Michael E Wechsler"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="wechslerm@njhealth.org"/>
  <meta name="citation_author" content="Angel CY Mak"/>
  <meta name="citation_author_institution" content="University of California San Francisco;"/>
  <meta name="citation_author_email" content="chiyan.mak@ucsf.edu"/>
  <meta name="citation_author" content="Celeste Eng"/>
  <meta name="citation_author_institution" content="University of California San Francisco;"/>
  <meta name="citation_author" content="Sandra Salazar"/>
  <meta name="citation_author_institution" content="University of California San Francisco;"/>
  <meta name="citation_author" content="Vivian Medina"/>
  <meta name="citation_author_institution" content="Centro de Neumologia Pediatrica;"/>
  <meta name="citation_author" content="Eric M Wohlford"/>
  <meta name="citation_author_institution" content="University of California San Francisco;"/>
  <meta name="citation_author" content="Scott Huntsman"/>
  <meta name="citation_author_institution" content="University of California San Francisco;"/>
  <meta name="citation_author" content="Deborah A Nickerson"/>
  <meta name="citation_author_institution" content="University of Washington;"/>
  <meta name="citation_author" content="Soren Germer"/>
  <meta name="citation_author_institution" content="New York Genome Center;"/>
  <meta name="citation_author" content="Michael C Zody"/>
  <meta name="citation_author_institution" content="New York Genome Center;"/>
  <meta name="citation_author" content="Goncalo Abecasis"/>
  <meta name="citation_author_institution" content="University of Michigan, Ann Arbor;"/>
  <meta name="citation_author" content="Hyun Min Kang"/>
  <meta name="citation_author_institution" content="University of Michigan, Ann Arbor;"/>
  <meta name="citation_author" content="Kenneth M Rice"/>
  <meta name="citation_author_institution" content="University of Washington;"/>
  <meta name="citation_author" content="Rajesh Kumar"/>
  <meta name="citation_author_institution" content="Lurie Children's Hospital"/>
  <meta name="citation_author" content="Sam Oh"/>
  <meta name="citation_author_institution" content="University of California San Francisco;"/>
  <meta name="citation_author" content="Jose Rodriguez-Santana"/>
  <meta name="citation_author_institution" content="Centro de Neumologia Pediatrica;"/>
  <meta name="citation_author" content="Esteban G Burchard"/>
  <meta name="citation_author_institution" content="University of California San Francisco;"/>
  <meta name="citation_author" content="Max A Seibold"/>
  <meta name="citation_author_institution" content="National Jewish Health;"/>
  <meta name="citation_author_email" content="seiboldm@njhealth.org"/>
  <meta name="twitter:title" content="Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="Coronavirus disease 2019 (COVID-19) outcomes vary from asymptomatic infection to death. This disparity may reflect different airway levels of the SARS-CoV-2 receptor, ACE2, and the spike protein activator, TMPRSS2. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci (eQTL) for both ACE2 and TMPRSS2, that vary in frequency across world populations. Importantly, we find TMPRSS2 is part of a mucus secretory network, highly upregulated by T2 inflammation through the action of interleukin-13, and that interferon response to respiratory viruses highly upregulates ACE2 expression. Finally, we define airway responses to coronavirus infections in children, finding that these infections upregulate IL6 while also stimulating a more pronounced cytotoxic immune response relative to other respiratory viruses. Our results reveal mechanisms likely influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-title" property="og:title" content="Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.04.09.034454v1"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="Coronavirus disease 2019 (COVID-19) outcomes vary from asymptomatic infection to death. This disparity may reflect different airway levels of the SARS-CoV-2 receptor, ACE2, and the spike protein activator, TMPRSS2. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci (eQTL) for both ACE2 and TMPRSS2, that vary in frequency across world populations. Importantly, we find TMPRSS2 is part of a mucus secretory network, highly upregulated by T2 inflammation through the action of interleukin-13, and that interferon response to respiratory viruses highly upregulates ACE2 expression. Finally, we define airway responses to coronavirus infections in children, finding that these infections upregulate IL6 while also stimulating a more pronounced cytotoxic immune response relative to other respiratory viruses. Our results reveal mechanisms likely influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-04-10"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1239256 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-category-new-results"> 
  <div class="article abstract-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2>Abstract</h2>
    <p id="p-2">Coronavirus disease 2019 (COVID-19) outcomes vary from asymptomatic infection to death. This disparity may reflect different airway levels of the SARS-CoV-2 receptor, ACE2, and the spike protein activator, TMPRSS2. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci (eQTL) for both ACE2 and TMPRSS2, that vary in frequency across world populations. Importantly, we find TMPRSS2 is part of a mucus secretory network, highly upregulated by T2 inflammation through the action of interleukin-13, and that interferon response to respiratory viruses highly upregulates ACE2 expression. Finally, we define airway responses to coronavirus infections in children, finding that these infections upregulate IL6 while also stimulating a more pronounced cytotoxic immune response relative to other respiratory viruses. Our results reveal mechanisms likely influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes.</p>
   </div>
   <h3>Competing Interest Statement</h3>
   <p id="p-3">The authors have declared no competing interest.</p>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
